Print Icon

May 2020

The future of metabolomics deserves everyone’s input. Include your voice to help shaping it. We would greatly appreciate if you would complete the following survey (approx. 5 mins). Once the survey is submitted, you will receive an entry to participate in the drawing for a choice of an iPad mini or an Apple watch. Thank you for taking the time to fill out the survey!


Tryptophan metabolism – Targeting immune response

Join Biocrates for a  live webinar on May 28th, at 16:00 CEST (10:00 AM EST) to learn more about the new Tryptophan Metabolism assay and its applicability to your research.

Meet Biocrates at ASMS Reboot

This year ASMS has taken the virtual route and will be accessible online. The official program is found here. Biocrates will have adedicated ASMS website, that will be active during the event allowing access tolive conversations and additional resources.


Monthly Focus Articles


Therapy response monitoring in infectious diseases

In our second part of the COVID-19 series, the utility of metabolomics to predict therapy response is described. This approach can reduce hospital burdon in the time of crisis. More


Lipidomics in cardiac patients after the Fontan procedure

Young adults who underwent the Fontan procedure as children (univentricular) were compared to healthy controls (biventricular) to investigate the long-term effects of the procedure on their metabolome.  More

Not interested? Unsubscribe | Update profile
Biocrates Life Sciences AG | Eduard-Bodem-Gasse 8; A- 6020 Innsbruck
Authorized representativeMoritz Seuster Co-CEO│CFO | Email | Phone+43512579823 | Tax Identification NumberATU56725128 | Company Registration Number220414p